These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 26456374

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain.
    Casonato A, De Marco L, Gallinaro L, Sztukowska M, Mazzuccato M, Battiston M, Pagnan A, Ruggeri ZM.
    Thromb Haemost; 2007 Apr; 97(4):527-33. PubMed ID: 17393013
    [Abstract] [Full Text] [Related]

  • 23. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z.
    Acta Haematol; 2009 Apr; 121(2-3):119-27. PubMed ID: 19506358
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers.
    O'Brien LA, Sutherland JJ, Hegadorn C, Benford K, Racz H, Rapson D, Hough C, Lillicrap D.
    J Thromb Haemost; 2004 Jul; 2(7):1135-42. PubMed ID: 15219197
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. An update on type 2B von Willebrand disease.
    Mikhail S, Aldin ES, Streiff M, Zeidan A.
    Expert Rev Hematol; 2014 Apr; 7(2):217-31. PubMed ID: 24521271
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation.
    Shen MC, Lin JS, Lin DS, Hsu SC, Lin B.
    Thromb Res; 2003 Apr; 112(5-6):291-5. PubMed ID: 15041272
    [Abstract] [Full Text] [Related]

  • 32. Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.
    Rayes J, Hollestelle MJ, Legendre P, Marx I, de Groot PG, Christophe OD, Lenting PJ, Denis CV.
    Blood; 2010 Jun 10; 115(23):4870-7. PubMed ID: 20200350
    [Abstract] [Full Text] [Related]

  • 33. Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets.
    Casari C, Paul DS, Susen S, Lavenu-Bombled C, Harroche A, Piatt R, Poe KO, Lee RH, Bryckaert M, Christophe OD, Lenting PJ, Denis CV, Bergmeier W.
    Blood Adv; 2018 Jun 26; 2(12):1417-1428. PubMed ID: 29925524
    [Abstract] [Full Text] [Related]

  • 34. A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.
    Hulstein JJ, de Groot PG, Silence K, Veyradier A, Fijnheer R, Lenting PJ.
    Blood; 2005 Nov 01; 106(9):3035-42. PubMed ID: 16014562
    [Abstract] [Full Text] [Related]

  • 35. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C, Hilbert L, Vanhoorelbeke K, Deckmyn H, Goudemand J, Mazurier C.
    Br J Haematol; 2006 Jun 01; 133(6):655-63. PubMed ID: 16704443
    [Abstract] [Full Text] [Related]

  • 36. The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease.
    Ay C, Pabinger I, Kovacevic KD, Gelbenegger G, Schörgenhofer C, Quehenberger P, Jilma-Stohlawetz P, Sunder-Plassman R, Gilbert JC, Zhu S, Jilma B, Derhaschnig U.
    Blood Adv; 2022 Sep 27; 6(18):5467-5476. PubMed ID: 35772170
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The impact of aberrant von Willebrand factor-GPIbα interaction on megakaryopoiesis and platelets in humanized type 2B von Willebrand disease model mouse.
    Kanaji S, Morodomi Y, Weiler H, Zarpellon A, Montgomery RR, Ruggeri ZM, Kanaji T.
    Haematologica; 2022 Sep 01; 107(9):2133-2143. PubMed ID: 35142156
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [von Willebrand factor and von Willebrand disease].
    Matsui T, Hamako J.
    Rinsho Ketsueki; 2016 Sep 01; 57(10):2113-2123. PubMed ID: 27795521
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.